Ticker Details
Organogenesis Holdings Inc.
IPO Date:	January 2, 2017
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$316.54M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 4.18%
Avg Daily Range (30 D):	$0.05 | 2.07%
Avg Daily Range (90 D):	$0.09 | 3.46%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.58M
Avg Daily Volume (90 D):	1.11M

Trade Size
Avg Trade Size (Sh.):	120
Avg Trade Size (Sh.) (30 D):	112
Avg Trade Size (Sh.) (90 D):	139

Institutional Trades
Total Institutional Trades:	926
Avg Institutional Trade:	$2.31M
Avg Institutional Trade (30 D):	$1.78M
Avg Institutional Trade (90 D):	$1.84M
Avg Institutional Trade Volume:	.37M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.04M
Avg Closing Trade (30 D):	$2.72M
Avg Closing Trade (90 D):	$1.35M
Avg Closing Volume:	259.58K

News

Apr 24, 2026 @ 7:54 AM Tissue Engineering Market to Grow at 12.95% CAGR R... Source: Mordor Intelligence

Apr 6, 2026 @ 11:02 PM Organogenesis Achieves Primary Endpoint in Randomi... Source: Na

Feb 3, 2026 @ 6:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 9:38 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Nov 20, 2025 @ 6:00 PM Global Wound Healing Devices Market Poised for Rob... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.15	$-.44	$.28
Diluted EPS	$-.16	$-.44	$.27
Revenue	$514.7M	$37.23M	$225.61M
Gross Profit
Net Income / Loss	$2.72M	$-53.16M	$43.7M
Operating Income / Loss	$2.55M	$-68.89M	$63.29M
Cost of Revenue
Net Cash Flow	$-18.44M	$-2.23M	$29.96M
PE Ratio